WASHINGTON and CAMBRIDGE, Mass., March 21, 2022 /PRNewswire-PRWeb/ -- Sorcero, the leading Life Sciences Language Intelligence Platform, announced the launch of their Clarity product today. For the first time, Clarity provides medical affairs teams with a unified view across all areas of scientific engagement. Life Sciences leaders have needed a strategic understanding of their scientific impact for a long time. Until Clarity, they were not able to centralize their strategy around evidence generation, publication planning, medical information, medical insights, and HEOR.
With Sorcero's AI-powered analytics, they can track and visualize medical content at scale. This includes literature, clinical trials, congresses, social media, CRM data, medical insights, and internal data lakes. Clarity surfaces emerging evidence, trends and drives better strategic decisions across the entire product lifecycle.
Medical affairs is becoming the third pillar of Life Sciences. Driven by demand for evidence-based and precision medicine, they must generate and disseminate evidence from more data sources than ever before, all while medical content is growing in both complexity and scale at a 36% CAGR. Clarity makes it possible to keep up and stay ahead, turning this deluge of information from their greatest challenge into their greatest asset. Clarity analyzes scientific and medical content at superhuman speeds to extract the most valuable evidence and power patient-centric decision making.
"At Sorcero, we are thrilled to support better decision making in support of improving patient outcomes," said Sorcero CEO Dipanwita Das. "We built Clarity to serve the need we heard loud and clear from the hundreds of interviews we conducted with medical affairs leaders. Their first ask was a unified view and analytics to drive actionable health outcomes informed by medical advances."
Clarity provides unprecedented accuracy and scale in extracting knowledge from life sciences content. Sorcero recently published real-world results from their AI hitting 96.1% NPV, the first life sciences language model to achieve regulatory-grade performance on medical literature.
About Sorcero
Sorcero is the leading life sciences language intelligence platform. Its advanced analytics enable 40% of the top 10 global life sciences organizations to gain clarity and complete visibility on the efficacy and impact of their scientific engagement on patient outcomes. Medical affairs teams rely on Sorcero to 10x their productivity, generate evidence, manage insights, and transform their medical strategy with real-time advanced analytics across the therapeutic landscape.
Sorcero is privately held and headquartered in Washington, DC, and Cambridge, MA. For more information, visit http://www.Sorcero.com.
Media Contact
Elizabeth Venafro, Sorcero, 202-571-4889, [email protected]
BOCA Communications for Sorcero, 202-571-4889, [email protected]
SOURCE Sorcero
Share this article